SCHEDULE OF OPERATIONS BY REPORTABLE SEGMENT (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Revenue	$ 20,275,000	$ 15,366,000
Depreciation and amortization	4,322,000	1,068,000
Interest expense	196,000	183,000
Stock based compensation	46,000	150,000
Income tax benefit	4,032,000	1,774,000
Net income (loss) from continuing operations	(36,169,000)	2,060,000
Capital expenditures	71,077,000	321,000
Identifiable assets	282,707,000	91,919,000
Operating Segments [Member] | Product Packaging [Member]
Segment Reporting Information [Line Items]
Revenue	15,315,000	13,040,000
Depreciation and amortization	612,000	736,000
Interest expense	62,000	102,000
Stock based compensation	3,000	12,000
Income tax benefit
Net income (loss) from continuing operations	710,000	1,329,000
Capital expenditures	4,296,000	260,000
Identifiable assets	23,575,000	10,715,000
Operating Segments [Member] | Commercial Banking [Member]
Segment Reporting Information [Line Items]
Revenue	250,000
Depreciation and amortization
Interest expense
Stock based compensation
Income tax benefit
Net income (loss) from continuing operations	(303,000)
Capital expenditures
Identifiable assets	32,964,000
Operating Segments [Member] | Direct Marketing Online Sales [Member]
Segment Reporting Information [Line Items]
Revenue	3,379,000	2,326,000
Depreciation and amortization	461,000	28,000
Interest expense	2,000
Stock based compensation
Income tax benefit
Net income (loss) from continuing operations	(17,709,000)	5,223,000
Capital expenditures	9,798,000	49,000
Identifiable assets	50,659,000	15,009,000
Operating Segments [Member] | Biotechnology [Member]
Segment Reporting Information [Line Items]
Revenue	83,000
Depreciation and amortization	1,113,000
Interest expense	1,000
Stock based compensation
Income tax benefit
Net income (loss) from continuing operations	(2,536,000)	(440,000)
Capital expenditures
Identifiable assets	56,425,000	48,118,000
Operating Segments [Member] | Securities [Member]
Segment Reporting Information [Line Items]
Revenue	1,196,000
Depreciation and amortization	1,833,000
Interest expense	114,000	101,000
Stock based compensation
Income tax benefit
Net income (loss) from continuing operations	(4,582,000)	(1,066,000)
Capital expenditures	56,794,000
Identifiable assets	64,701,000	2,820,000
Operating Segments [Member] | Corporate Segment [Member]
Segment Reporting Information [Line Items]
Revenue	52,000
Depreciation and amortization	303,000	304,000
Interest expense	17,000	(20,000)
Stock based compensation	43,000	138,000
Income tax benefit		1,774,000
Net income (loss) from continuing operations	(11,749,000)	(2,986,000)
Capital expenditures	189,000	12,000
Identifiable assets	$ 54,383,000	$ 15,257,000